Polyzos SA - Search Results

1

Impact of Helicobacter pylori-related metabolic syndrome with hyperhomocysteinemia on extragastric pathologies.

Kountouras J, Doulberis M, Polyzos SA, Kazakos E, Vardaka E, Touloumtzi M, Manolakis A, Tzitiridou-Chatzopoulou M, Liatsos C, Sotiriades ES, Ntona S, Papaefthymiou A. Kountouras J, et al. Among authors: polyzos sa. J Gastroenterol Hepatol. 2022 Feb;37(2):407-408. doi: 10.1111/jgh.15753. Epub 2021 Dec 15. J Gastroenterol Hepatol. 2022. PMID: 34894006 No abstract available.

2

Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. Curr Mol Med. 2009 Apr;9(3):299-314. doi: 10.2174/156652409787847191. Curr Mol Med. 2009. PMID: 19355912 Review.

3

The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease.

Polyzos SA, Kountouras J, Zavos Ch. Polyzos SA, et al. Hippokratia. 2009 Apr;13(2):127; author reply 128. Hippokratia. 2009. PMID: 19561788 Free PMC article. No abstract available.

4

Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. J Clin Gastroenterol. 2010 Mar;44(3):229-30; author reply 230-1. doi: 10.1097/MCG.0b013e3181b5ce68. J Clin Gastroenterol. 2010. PMID: 19770674 No abstract available.

5

Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis.

Polyzos SA, Kountouras J, Zavos C. Polyzos SA, et al. Hepatol Res. 2010 Apr;40(4):446-7. doi: 10.1111/j.1872-034X.2010.00632.x. Hepatol Res. 2010. PMID: 20394676 No abstract available.

6

Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.

Polyzos SA, Kountouras J, Anastasilakis AD, Litsas I, Kita M, Arsos G, Moralidis E, Terpos E. Polyzos SA, et al. Osteoporos Int. 2011 Jan;22(1):363-7. doi: 10.1007/s00198-010-1230-5. Epub 2010 Apr 21. Osteoporos Int. 2011. PMID: 20407889

7

The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.

Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. Polyzos SA, et al. Diabetes Obes Metab. 2010 May;12(5):365-83. doi: 10.1111/j.1463-1326.2009.01176.x. Diabetes Obes Metab. 2010. PMID: 20415685 Review.

8

The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature.

Polyzos SA, Kountouras J, Zavos C, Deretzi G. Polyzos SA, et al. J Clin Gastroenterol. 2011 Jan;45(1):50-4. doi: 10.1097/MCG.0b013e3181ec5c66. J Clin Gastroenterol. 2011. PMID: 20717042 Review.

9

Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction.

Kountouras J, Zavos C, Deretzi G, Gavalas E, Polyzos S, Katsinelos P, Grigoriadis N, Koutlas E, Rudolf J, Tsiptsios I. Kountouras J, et al. J Neuroimmunol. 2011 Apr;233(1-2):254-6; author reply 257-8. doi: 10.1016/j.jneuroim.2010.09.022. Epub 2010 Oct 20. J Neuroimmunol. 2011. PMID: 20965574 No abstract available.

10

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J. Polyzos SA, et al. Metabolism. 2011 Mar;60(3):313-26. doi: 10.1016/j.metabol.2010.09.003. Epub 2010 Oct 30. Metabolism. 2011. PMID: 21040935 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters